Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04529941 · ClinicalTrials.gov registry record · NA
Using Electrical Nerve Stimulation to Control Atrial Fibrillation
A NA study, sponsored by Cedars-Sinai Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 46
- Enrollment target
NCT04529941 is a NA study that has completed, run by Cedars-Sinai Medical Center. The registered enrollment target is 46 participants.
The verdict
NCT04529941, a NA study, has completed, sponsored by Cedars-Sinai Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 46 participants
- Enrollment target
Study Summary
The purpose of this study is to examine if sending mild electrical signals just under your skin will improve atrial fibrillation symptoms by controlling your heart rate.
Interventions
- DEVICE Device Implant with Active Treatment
- DEVICE Device Implant without Active Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2021-11-24 |
| Est. Completion | 2024-09-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04529941
The ClinicalTrials.gov registry entry for NCT04529941 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cedars-Sinai Medical Center, which has 339 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Device Implant with Active Treatment is the first listed.
NCT04529941 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04529941 about?
NCT04529941 is a clinical study titled "Using Electrical Nerve Stimulation to Control Atrial Fibrillation". The purpose of this study is to examine if sending mild electrical signals just under your skin will improve atrial fibrillation symptoms by controlling your heart rate.
What is the current status of trial NCT04529941?
This trial is currently completed. It is a NA study. The enrollment target is 46 participants. The study started on 2021-11-24. Estimated completion is 2024-09-25.
What interventions are being tested in trial NCT04529941?
The interventions under investigation include: Device Implant with Active Treatment (DEVICE), Device Implant without Active Treatment (DEVICE).
Who is sponsoring clinical trial NCT04529941?
This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.